• CVS Health raised its 2026 adjusted earnings forecast to at least $8.20 a share from $7.90-$8.10.
• Total revenue guidance increased to at least $420 billion from at least $414 billion.
• Operating cash flow is forecast at at least $15.5 billion, up from at least $11.5 billion.
• Adjusted operating income guidance rose to at least $17.05 billion from $16.58 billion-$16.92 billion.
• Health Care Benefits adjusted operating income is expected to reach at least $5.4 billion, versus the previous $5.03 billion-$5.37 billion range.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.